Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07154511
PHASE1/PHASE2

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

Sponsor: Prabesh Kanel

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation. The main questions it aims to answer are: 1. Does tributyrin improve memory/thinking test scores and walking/balance ability? 2. What medical problems do participants have when taking tributyrin? Researchers will compare tributyrin to a placebo (a look-alike substance that contains no drug) to see if tributyrin works to treat Parkinson disease symptoms. Participants will: 1. Take tributyrin 3 times a day for 80-100 days 2. Complete motor and cognitive testing at the clinic before and after the supplementation period 3. Complete brain imaging (MRI scans and PET scans) before and after the supplementation period.

Key Details

Gender

All

Age Range

45 Years - Any

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2025-11-07

Completion Date

2027-05

Last Updated

2025-11-12

Healthy Volunteers

No

Interventions

DRUG

Tributyrin

Post-biotic short chain fatty acid dietary supplement. Participants will take 500mg TID tributyrin supplement for 90 days +/- 7 days.

DRUG

Placebo

Participants will take 500mg TID placebo for 90 days +/- 7 days.

Locations (1)

Domino's Farms

Ann Arbor, Michigan, United States